Drugs / Cellular Stromal Vascular Fraction
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07546942 | Apr 2026 → Jun 2030 expected | autism | Black Tie Medical, Inc. | Enrolling by invitation | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellular Stromal Vascular Fraction | “Autologous Cellular Stromal Vascular Fraction (cSVF)” NCT07546942 ↗ |
| Known as | cSVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07546942 ↗ |
| Modality | Cell therapy | “Autologous Cellular Stromal Vascular Fraction (cSVF)” NCT07546942 ↗ |
| Route | Intravenous | “Administration: Intravenous (IV) route with in-line sterile 150u filtration” NCT07546942 ↗ |